Renal alpha 2-adrenergic receptors multiply and mediate sodium retention after prazosin treatment
- PMID: 3007352
- DOI: 10.1161/01.hyp.8.4.323
Renal alpha 2-adrenergic receptors multiply and mediate sodium retention after prazosin treatment
Abstract
Renal nerve stimulation-induced antinatriuresis normally is mediated through post-synaptic alpha 1-adrenergic receptors; however, prazosin-induced alpha 1-adrenergic receptor blockade is associated clinically with sodium retention and not natriuresis. To study whether alpha 2-adrenergic receptors mediate renal nerve stimulation-induced antinatriuresis after chronic prazosin treatment, Sprague-Dawley rats were pretreated for 3 days with prazosin (3 mg/kg/day i.p. plus 0.15 mg/ml drinking water) or vehicle (untreated). In isolated perfused (Krebs-Henseleit; Ficoll, 3.5 g/dl, + albumin, 1.0 g/dl at 36 degrees C) kidneys from untreated rats, subpressor levels of renal nerve stimulation (approximately 1 Hz, 10 V, 1 msec) decreased (p less than 0.05) sodium (from 4.50 +/- 0.42 to 1.71 +/- .23 muEq/min) and urinary excretion rate (from 87.2 +/- 4.1 to 57.9 +/- 3.9 microliter/min). Adding prazosin (30 nM) to the perfusate completely (approximately 90%) reversed this effect (p less than 0.05), while alpha 2-adrenergic receptor blockade with yohimbine (300 nM) had no effect. In perfused kidneys from prazosin-treated rats, renal nerve stimulation decreased (p less than 0.05) sodium (from 3.24 +/- .40 to 1.32 +/- .27 muEq/min) and urinary excretion rate (from 78.7 +/- 5.0 to 54.1 +/- 5.3 microliter/min). However, adding prazosin (100 nM) to the perfusate produced only a slight, insignificant reversal of these effects; prazosin plus yohimbine were required to completely reverse the effects. These results suggest that renal nerve stimulation-induced sodium reabsorption was activated by alpha 1-adrenergic receptors in untreated rats and in part by alpha 2-adrenergic receptors in rats pretreated for 3 days with prazosin.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Renal nerve stimulation causes alpha 1-adrenoceptor-mediated sodium retention but not alpha 2-adrenoceptor antagonism of vasopressin.Circ Res. 1985 Aug;57(2):304-11. doi: 10.1161/01.res.57.2.304. Circ Res. 1985. PMID: 2990759
-
Alpha 1-adrenoceptor blockade and altered renal alpha 2-adrenoceptors: a model(?) for the study of genetically altered alpha 2-adrenoceptors in hypertensive rats.J Hypertens Suppl. 1986 Oct;4(3):S205-8. J Hypertens Suppl. 1986. PMID: 3023587
-
Prazosin-induced alterations in renal alpha-adrenergic receptor function.Hypertension. 1987 Jun;9(6 Pt 2):III125-9. doi: 10.1161/01.hyp.9.6_pt_2.iii125. Hypertension. 1987. PMID: 2885271
-
Renal alpha-adrenergic receptors and genetic hypertension.Pediatr Nephrol. 1993 Dec;7(6):853-8. doi: 10.1007/BF01213373. Pediatr Nephrol. 1993. PMID: 8130120 Review.
-
Prazosin.2018 Jan 8. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2018 Jan 8. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644009 Free Books & Documents. Review.
Cited by
-
Interaction between alpha 2-adrenergic and angiotensin II systems in the control of glomerular hemodynamics as assessed by renal micropuncture in the rat.J Clin Invest. 1992 Aug;90(2):604-11. doi: 10.1172/JCI115899. J Clin Invest. 1992. PMID: 1353766 Free PMC article.
-
Cardiovascular actions of a new selective postjunctional alpha-adrenoceptor antagonist, SK&F 104856, in normotensive and hypertensive dogs.Br J Pharmacol. 1992 Apr;105(4):992-6. doi: 10.1111/j.1476-5381.1992.tb09090.x. Br J Pharmacol. 1992. PMID: 1354539 Free PMC article.
-
Chronic prazosin attenuates the natriuretic response to a modest saline load in anaesthetized rats.Br J Pharmacol. 1988 Feb;93(2):446-52. doi: 10.1111/j.1476-5381.1988.tb11452.x. Br J Pharmacol. 1988. PMID: 2896036 Free PMC article.
-
Acute effect of an alpha 1-adrenoceptor antagonist on urinary sodium excretion, plasma atrial natriuretic peptide, arginine vasopressin, and the renin-aldosterone system in healthy subjects.Eur J Clin Pharmacol. 1992;43(1):17-21. doi: 10.1007/BF02280748. Eur J Clin Pharmacol. 1992. PMID: 1354618 Clinical Trial.
-
The effects of alpha-adrenoceptor blockade on dopamine-induced renal vasodilation and natriuresis.Naunyn Schmiedebergs Arch Pharmacol. 1991 Feb;343(2):143-8. doi: 10.1007/BF00168601. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 2067587
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources